XML 70 R57.htm IDEA: XBRL DOCUMENT v3.22.1
Related Parties Transactions (Details) - USD ($)
1 Months Ended 12 Months Ended
May 08, 2020
May 11, 2018
Oct. 31, 2020
Feb. 24, 2015
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 01, 2021
Sep. 30, 2021
Sep. 07, 2021
Jul. 01, 2020
Feb. 27, 2019
Related Parties Transactions (Details) [Line Items]                          
Due from Rgene amounted                     $ 67,873    
Stock purchase agreement, description         Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the maturity date was December 31, 2020.                
Outstanding principal and accrued interest         $ 168,131 $ 166,261              
Due from rgene         $ 1,889                
Loan agreement, description               The advances bear interest rate from 12% to 13.6224% per annum.          
Interest rate percentage         1.50%                
Outstanding balance and accrued interest         $ 393,424 288,445              
Interest expenses         22,779 21,520              
Due to employee amount         $ 0 72,705              
YuanGene [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Interest rate percentage         0.00%                
Aggregate working capital         $ 9,205                
Rgene Corporation [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Due from Rgene amounted         49,110 42,911              
Balance of outstanding loans         33,520 31,684              
Outstanding principal and accrued interest         $ 13,701 11,227              
Loan agreement, description         Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the loan maturity date was December 31, 2020.                
AsiaGene [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Balance of outstanding loans         $ 0 3,560              
Outstanding principal and accrued interest         $ 0 681              
Interest rate percentage         0.00%                
Aggregate working capital         $ 24,017 0              
BioFirst [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Balance of outstanding loans         465,000 0              
Outstanding principal and accrued interest         $ 3,435 0              
Loan agreement, description         the Company and BioFirst entered into loan agreements for a total amount of $45,000, $140,000, and $280,000, respectively, to meet its working capital needs. The loan will be matured on November 1, 2022, November 11, 2022, and December 19, 2022, respectively, all with an interest rate of 6.5% per annum.   The advances bear interest 1% per month (or equivalent to 12% per annum).            
Outstanding balance and accrued interest         $ 40,878 23,647              
BioFirst (Australia) [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Due from Rgene amounted                       $ 361,487  
Balance of outstanding loans         491,816 373,235              
Interest rate percentage                   6.50%      
Advances bear interest, description   The advances bear 0% interest rate and are due on demand.                      
Aggregate working capital         0 132,443              
BHK Co Development Aggreement [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loan agreement, description       The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                  
Due from BHK         124,972 123,583              
LBG USA, Inc.[Member]                          
Related Parties Transactions (Details) [Line Items]                          
Interest rate percentage                         0.00%
Outstanding advance         675 675              
BioLite Japan [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loan agreement, description Based on the LOI, each party will advance an aggregated amount of $150,000 to meet BioLite Japan’s working capital needs, which the Company advanced an amount of $150,000 and the advance bear 0% interest rate.                        
Outstanding advance         150,000 150,000              
Aggregate working capital $ 150,000                        
Keypoint [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Balance of outstanding loans         $ 1,610 $ 1,610              
Loan agreement, description     the Company has advanced an aggregate amount of $1,610 to Keypoint for working capital purpose. Under the terms of the loan agreement, the loan bears interest at 6.5% per annum and the loan will be matured on October 30, 2021.                    
Jiangs [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Interest rate percentage         0.00% 1.00%              
Outstanding balance and accrued interest         $ 18,750 $ 16,627              
BioFirst (Australia) [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Due from Rgene amounted                 $ 250,000        
Interest rate percentage                 6.50%